SCHEMBL198906

SCHEMBL198906

[CH2]CCC(CCC)CCCCC

nearest known ligand 0.46

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.46
OPRM1 P35372 1/20 0.39
ALDH1A1 P00352 3/20 0.36
TDP1 Q9NUW8 1/20 0.36
DNM1 Q05193 2/20 0.35
TSHR P16473 3/20 0.34
CYP3A4 P08684 1/20 0.34
FDPS P14324 3/20 0.33
THRB P10828 1/20 0.33
GPR84 Q9NQS5 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL101205 0.98 LMNA (0.50) LMNAOPRM1ALDH1A1TDP1DNM1
SCHEMBL102016 0.98 LMNA (0.50) LMNAOPRM1ALDH1A1TDP1DNM1
SCHEMBL200764 0.98 LMNA (0.50) LMNAOPRM1ALDH1A1TDP1DNM1
SCHEMBL199467 0.98 LMNA (0.50) LMNAOPRM1ALDH1A1TDP1DNM1
SCHEMBL200292 0.98 LMNA (0.50) LMNAOPRM1ALDH1A1TDP1DNM1
SCHEMBL102488 0.98 LMNA (0.50) LMNAOPRM1ALDH1A1TDP1DNM1
SCHEMBL202435 0.98 LMNA (0.50) LMNAOPRM1ALDH1A1TDP1DNM1
SCHEMBL100414 0.98 LMNA (0.50) LMNAOPRM1ALDH1A1TDP1DNM1
SCHEMBL101403 0.98 LMNA (0.50) LMNAOPRM1ALDH1A1TDP1DNM1
SCHEMBL103553 0.98 LMNA (0.50) LMNAOPRM1ALDH1A1TDP1DNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3074415-A1 NOVEL ULTRASHORT HYDROPHOBIC PEPTIDES THAT SELF-ASSEMBLE INTO NANOFIBROUS HYDROGELS AND THEIR USES Agency For Science, Technology And Research (SG) 2016-10-05 EP claimed
WO-2015080670-A1 NOVEL ULTRASHORT HYDROPHOBIC PEPTIDES THAT SELF-ASSEMBLE INTO NANOFIBROUS HYDROGELS AND THEIR USES AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2015-06-04 WO claimed
CN-118201905-A Cationic lipid 武田药品工业株式会社 2024-06-14 CN disclosed
WO-2024112546-A1 LIQUID WEIGHTING AGENTS FOR OIL-BASED FLUIDS ALBEMARLE CORPORATION (US) 2024-05-30 WO disclosed
US-20240090517-A1 Microbiocidal Control in The Processing of Poultry ALBEMARLE CORPORATION 2024-03-21 US disclosed
CN-117044717-A Microbiocidal control in poultry processing 雅宝公司 2023-11-14 CN disclosed
CN-116268052-A Microbiocidal control in poultry processing 雅宝公司 2023-06-23 CN disclosed
WO-2023085299-A1 CATIONIC LIPID 武田薬品工業株式会社 2023-05-19 WO disclosed
CN-116113657-A Alkoxylated polymeric N- (hydroxyalkyl) amines as wetting agents and as components of defoamer compositions 巴斯夫欧洲公司 2023-05-12 CN disclosed
US-11156619-B2 Fluorescent pH sensors and methods of preparing them ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2021-10-26 US disclosed
CN-105189532-B Self-assembled ultrashort peptide hydrogels for wound healing, skin care and cosmetic applications 新加坡科技研究局 2020-11-03 CN disclosed
WO-2010111822-A1 OLIGOCONDENSED PERYLENE BISIMIDES BASF SE (DE) 2010-10-07 WO disclosed
US-20100048904-A1 DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS BASF AKTIENGESELLSCHAFT (DE) 2010-02-25 US disclosed
EP-2029573-A1 DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS BASF SE (DE) 2009-03-04 EP disclosed
EP-2008319-A2 LIQUID CRYSTALLINE RYLENE TETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF BASF SE (DE) 2008-12-31 EP disclosed
WO-2007138051-A1 DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS BASF SE (DE) 2007-12-06 WO disclosed
WO-2007116001-A2 LIQUID CRYSTALLINE RYLENE TETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF BASF SE (DE) 2007-10-18 WO disclosed
EP-1843407-A1 Liquid crystalline rylenetetracarboxylic acid derivatives and their use BASF AKTIENGESELLSCHAFT (DE) 2007-10-10 EP disclosed
US-4618627-A ALLERGIES YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1986-10-21 US disclosed
EP-0125919-A2 Catechol derivatives, their production and intermediates therefor, and pharmaceutical compositions containing them YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1984-11-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048904-A1 DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS TDO2, C9, CYP3A43 LMNA 1646/4885OPRM1 1941/4885ALDH1A1 627/4885
US-11156619-B2 Fluorescent pH sensors and methods of preparing them PHF8, PHF6, H1-0 LMNA 577/4885OPRM1 2560/4885ALDH1A1 403/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.